Kazakhstan Pharmaceuticals and Healthcare Report Q2 2012Business Monitor International
March 6, 2012
81 Pages - SKU: BMI3805217
More Prescription Drugs reports by Business Monitor International
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Sudan will remain one of the least attractive countries in the Middle East/Africa region due tolow pharmaceutical and healthcare expenditure. The government's low ...
Pakistan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Increased longevity in developed markets translates into an increased demand for aged carehealthcare services and medicines. However, in emerging markets such as Pakistan, ...
Japan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Japan remains the most attractive market in the Asia Pacific, due to the ageing and affluentpopulation and strong regulatory conditions. In particular, we ...
Croatia Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor InternationalSee all reports like this >>
Executive SummaryBMI View: Croatia's entrance into the EU will accelerate its economic liberalisation and the developmentof the country's private sector. It is also likely to ...
More Kazakhstan Prescription Drugs reports
Kazakhstan Pharmaceuticals and Healthcare Report Q2 2013 by Business Monitor International
BMI View: Kazakhstan remains the most attractive pharmaceutical market in Central Asia, in terms ofthe overall regulatory environment and ease of doing business compared to ...
Antibiotics Market in Kazakhstan to 2016 by Global Research & Data ServicesSee all reports like this >>
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Kazakhstan. The study provides essential market ...
More Kazakhstan reports
D&B Country RiskLine Report: Kazakhstan by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Kazakhstan by Dun & Bradstreet Inc.See all reports like this >>
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Hospitals & Clinics
- Country Overviews
- Life Sciences
- Country Overviews
- Manufacturing, Packaging & Detailing
- Prescription Drugs
Prescription Drugs Reports